Alpha Crest Capital Management LLC Cara Therapeutics, Inc. Transaction History

Alpha Crest Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$15.07 - $21.71 $265,232 - $382,096	-17,600 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$12.72 - $16.16 $26,712 - $33,936	-2,100 Reduced 10.66%	17,600 $266,000
Q3 2020 Nov 12, 2020	BUY	$12.34 - $17.92 $243,098 - $353,024	19,700 New	19,700 $251,000
Q2 2019 Aug 12, 2019	SELL	$17.68 - $21.57 $231,608 - $282,567	-13,100 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$14.41 - $19.64 $188,771 - $257,284	13,100 New	13,100 $257,000

826K

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $277M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.